The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During the covid-19 pandemic the UK ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine demand and pipeline ...

A former NYU housing manager is suing the university for religious-based discrimination, claiming he was wrongfully ...

The pandemic death total stands at 1,252 as of February 1, 2025 (the most recent data available). The 5 reported deaths last ...

Polaris is a contrarian investment opportunity with a high dividend yield, strong financial stability, and potential for ...